| Uterine neoplasms, version 1.2023, NCCN clinical practice guidelines in oncology N Abu-Rustum, C Yashar, R Arend, E Barber, K Bradley, R Brooks, ... Journal of the National Comprehensive Cancer Network 21 (2), 181-209, 2023 | 159 | 2023 |
| NCCN Guidelines® insights: uterine neoplasms, version 3.2021: featured updates to the NCCN guidelines NR Abu-Rustum, CM Yashar, K Bradley, SM Campos, J Chino, HS Chon, ... Journal of the National Comprehensive Cancer Network 19 (8), 888-895, 2021 | 130 | 2021 |
| An international series on abdominal radical trachelectomy: 101 patients and 28 pregnancies SL Wethington, D Cibula, LR Duska, L Garrett, CH Kim, DS Chi, Y Sonoda, ... International Journal of Gynecologic Cancer 22 (7), 2012 | 124 | 2012 |
| Risk and predictors of malignancy in women with endometrial polyps SL Wethington, TJ Herzog, WM Burke, X Sun, JP Lerner, SN Lewin, ... Annals of surgical oncology 18, 3819-3823, 2011 | 124 | 2011 |
| Clinical outcome of isolated serous tubal intraepithelial carcinomas (STIC) SL Wethington, KJ Park, RA Soslow, ND Kauff, CL Brown, F Dao, ... International Journal of Gynecologic Cancer 23 (9), 2013 | 122 | 2013 |
| Expanding the indications for radical trachelectomy: a report on 29 patients with stage IB1 tumors measuring 2 to 4 centimeters SL Wethington, Y Sonoda, KJ Park, KM Alektiar, WP Tew, DS Chi, ... International Journal of Gynecologic Cancer 23 (6), 2013 | 101 | 2013 |
| Primary cytoreductive surgery and adjuvant hormonal monotherapy in women with advanced low-grade serous ovarian carcinoma: Reducing overtreatment without compromising survival? AN Fader, J Bergstrom, A Jernigan, EJ Tanner III, KL Roche, RL Stone, ... Gynecologic oncology 147 (1), 85-91, 2017 | 93 | 2017 |
| Improved survival for fallopian tube cancer: a comparison of clinical characteristics and outcome for primary fallopian tube and ovarian cancer SL Wethington, TJ Herzog, VE Seshan, N Bansal, PB Schiff, WM Burke, ... Cancer 113 (12), 3298-3306, 2008 | 83 | 2008 |
| Prognostic significance and treatment implications of positive peritoneal cytology in endometrial adenocarcinoma: unraveling a mystery SL Wethington, NIB Medel, JD Wright, TJ Herzog Gynecologic oncology 115 (1), 18-25, 2009 | 80 | 2009 |
| Minimally invasive hysterectomy surgery rates for endometrial cancer performed at National Comprehensive Cancer Network (NCCN) Centers J Bergstrom, A Aloisi, S Armbruster, TT Yen, J Casarin, MM Leitao Jr, ... Gynecologic oncology 148 (3), 480-484, 2018 | 75 | 2018 |
| Combination ATR and PARP Inhibitor (CAPRI): A phase 2 study of ceralasertib plus olaparib in patients with recurrent, platinum-resistant epithelial ovarian cancer PD Shah, SL Wethington, C Pagan, N Latif, J Tanyi, LP Martin, M Morgan, ... Gynecologic oncology 163 (2), 246-253, 2021 | 68 | 2021 |
| When to operate, hesitate and reintegrate: society of gynecologic oncology surgical considerations during the COVID-19 pandemic AN Fader, WK Huh, J Kesterson, B Pothuri, S Wethington, JD Wright, ... Gynecologic oncology 158 (2), 236-243, 2020 | 65 | 2020 |
| Outcomes associated with a five-point surgical site infection prevention bundle in women undergoing surgery for ovarian cancer MH Lippitt, MG Fairbairn, R Matsuno, RL Stone, EJ Tanner III, EC Wick, ... Obstetrics & Gynecology 130 (4), 756-764, 2017 | 59 | 2017 |
| Endometrial carcinomas with clear cells: a study of a heterogeneous group of tumors including interobserver variability, mutation analysis, and immunohistochemistry with HNF-1β G Han, RA Soslow, S Wethington, DA Levine, F Bogomolniy, PB Clement, ... International Journal of Gynecological Pathology 34 (4), 323-333, 2015 | 52 | 2015 |
| Narcotics reduction, quality and safety in gynecologic oncology surgery in the first year of enhanced recovery after surgery protocol implementation JE Bergstrom, ME Scott, Y Alimi, TT Yen, D Hobson, KK Machado, ... Gynecologic oncology 149 (3), 554-559, 2018 | 49 | 2018 |
| Key role of topoisomerase I inhibitors in the treatment of recurrent and refractory epithelial ovarian carcinoma SL Wethington, JD Wright, TJ Herzog Expert review of anticancer therapy 8 (5), 819-831, 2008 | 49 | 2008 |
| Results of an early safety analysis of a study of the combination of pembrolizumab and pelvic chemoradiation in locally advanced cervical cancer LR Duska, JM Scalici, SM Temkin, JK Schwarz, EK Crane, KM Moxley, ... Cancer 126 (22), 4948-4956, 2020 | 46 | 2020 |
| The addition of metformin to progestin therapy in the fertility-sparing treatment of women with atypical hyperplasia/endometrial intraepithelial neoplasia or endometrial cancer … S Acosta-Torres, T Murdock, R Matsuno, AL Beavis, RL Stone, ... Gynecologic oncology 157 (2), 348-356, 2020 | 44 | 2020 |
| The utility and cost effectiveness of preoperative computed tomography for patients with uterine malignancies N Bansal, TJ Herzog, A Brunner-Brown, SL Wethington, CJ Cohen, ... Gynecologic oncology 111 (2), 208-212, 2008 | 43 | 2008 |
| Risk of empty lymph node packets in sentinel lymph node mapping for endometrial cancer using indocyanine green L Thomaier, L Jager, R Stone, S Wethington, A Fader, EJ Tanner International Journal of Gynecologic Cancer 29 (3), 2019 | 37 | 2019 |
Amanda Nickles FaderJohns Hopkins在 jhmi.edu 的电子邮件经过验证
